Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.27133 | 51 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.16406 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.1671 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.10069 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.07156 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.33886 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.30007 | 51 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.14621 | 49 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.13893 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.14671 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.16544 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16058 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.21288 | 50 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.16522 | 49 |